FINISHED DOSAGE FORMULATIONS
FDF DOSSIERS SUPPLIERS
Drug : ZEMPLAR
Dosage Form : CAPSULE; ORAL
Application Number : 21606
Country : US
Patented : No
Drug : NORVIR
Dosage Form : CAPSULE; ORAL
Application Number : 20945
Country : US
Patented : No
Drug : TRETINOIN
Dosage Form : CREAM; TOPICAL
Application Number : 90098
Country : US
Patented : No
Drug : CONDYLOX
Dosage Form : GEL; TOPICAL
Application Number : 20529
Country : US
Patented : No
Drug : GELNIQUE 3%
Dosage Form : GEL, METERED; TRANSDERMAL
Application Number : 202513
Country : US
Patented : No
Drug : TRETINOIN
Dosage Form : CREAM; TOPICAL
Application Number : 202209
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM; BUCCAL, SUBLINGUAL
Application Number : 205299
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213473
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : FILM; BUCCAL, SUBLINGUAL
Application Number : 205806
Country : US
Patented : No
Drug : SOLIFENACIN SUCCINATE
Dosage Form : TABLET; ORAL
Application Number : 209818
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]MARKET PLACE
